Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 10

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 10
---
 transaction (the “Offering”) on February 19, 2025 (including shares of Common Stock
issuable upon operation of certain anti-dilutions provisions applicable to such Series Warrants, and shares of Common Stock issuable
upon “alternative cashless exercise” feature in the Series B Warrants).

<div align='center'>4</div>

Proposal 2 (the “Reverse Stock Split Proposal”):

To approve an amendment to our Amended and Restated Certificate of
Incorporation, as amended (the “Charter”) to effect, at the discretion of the Board but prior to the one-year anniversary
of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split
of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined
by the board of directors (the “Board”) of the Company in its discretion and included in a public announcement.

Proposal 3 (the “Plan Amendment Proposal”):

To approve the Third Amendment to the Petros Pharmaceuticals, Inc.
Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s
Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock.

Proposal 4 (the “Share Increase Proposal”):

To approve an amendment to the Charter, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 sharesand to make a corresponding
change to the number of authorized shares of capital stock.

Proposal 5 (the “Adjournment Proposal”):

To approve a proposal to adjourn the Special Meeting to a later date
or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes
for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.

To consider and act upon
any other business as may properly come before the Special Meeting or any postponement or adjournment thereof.

How Do I Vote?

Whether you plan to attend
the Special Meeting or not, we urge you to vote by proxy. All shares represented by valid proxies that we receive, and that are not revoked,
will be